CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.
Source: US Top News and Analysis
Related Posts
Stock futures slip as oil prices resume their climb; S&P 500 creeps closer to correction territory: Live updates
The broad market S&P 500 fell for a third consecutive session on Monday as oil…
How a perilous U.S. rescue mission in Iran nearly went off course
The rescued U.S. weapons specialist was the second of two crew members on an F-15E…
Franklin Templeton acquires digital assets investment firm in active crypto management push
Franklin Templeton has agreed to buy 250 Digital, which will join the newly established unit…